2010
DOI: 10.1097/mnh.0b013e32833aff4a
|View full text |Cite
|
Sign up to set email alerts
|

Thrombotic microangiopathies: new insights and new challenges

Abstract: As the underlying disease mechanisms of TMA are now being better understood new options for a more precise diagnosis, improved therapy and prognosis for kidney transplantation become available for the benefit of patients. Here we summarize the recent developments in this rapidly progressing field.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
0
6

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 50 publications
(37 citation statements)
references
References 57 publications
1
30
0
6
Order By: Relevance
“…Patients with active AAV have elevated levels of circulating C3a, C5a, soluble C5b-9, and Bb, which suggests activation of the complement system via the alternative pathway (30). As for TMA, a variety of hereditary and acquired disorders, which contribute to the loss of alternative pathway regulation on endothelial cells and on the surface of platelets, have been documented and predispose patients to TMA susceptibility (31)(32)(33)(34). Indeed, it has been suggested that most TMAs are characterized by misdirected complement activation affecting endothelial cell and platelet integrity (34).…”
Section: Discussionmentioning
confidence: 99%
“…Patients with active AAV have elevated levels of circulating C3a, C5a, soluble C5b-9, and Bb, which suggests activation of the complement system via the alternative pathway (30). As for TMA, a variety of hereditary and acquired disorders, which contribute to the loss of alternative pathway regulation on endothelial cells and on the surface of platelets, have been documented and predispose patients to TMA susceptibility (31)(32)(33)(34). Indeed, it has been suggested that most TMAs are characterized by misdirected complement activation affecting endothelial cell and platelet integrity (34).…”
Section: Discussionmentioning
confidence: 99%
“…A specific plasma protease, the ADAMTS13 gene, is responsible for the physiologic degradation of vWF and plays a pathogenic role in a substantial proportion of familial and acute idiopathic cases of TTP. 8 A deficiency in ADAMTS13 enzyme levels, along with an inhibitory antibody, is found in most patients with idiopathic TTP. Multiple triggers, such as infection, drugs, cancer, chemotherapy, bone marrow transplantation, and pregnancy, are recognized.…”
Section: Discussionmentioning
confidence: 99%
“…Several complement genes are mutated in HUS. 8 Multifocal TMA with intimal-medial dissection by thrombi extending from foci of endothelial damage in small cerebral arteries and arterioles can be secondary to toxins. 10,11 A drug as the toxin is a rare cause of TMA.…”
Section: Discussionmentioning
confidence: 99%
“…Pregnant women and women in the postpartum period accounted for a notable portion (12-31%; about 1 each 25,000 pregnancies) of the cases in some studies. For this reason TTP predominantly affects female subjects between 10 and 40 years old [5,6].…”
Section: Thrombotic Thrombocytopenic Purpura (Ttp)mentioning
confidence: 99%
“…These features are really common to various disorders, however Thrombotic Thrombocytopenic Purpura (TTP) and the Hemolytic-Uremic Syndrome (HUS), represent the major and more investigated forms whose pathogenesis has been clarified only in the last three decades [2][3][4]. Both TTP and HUS occur at a frequency of approximately 1-6 cases per one million people, may affect children and adults, and may each have several distinct subtypes with overlapping symptoms, but caused by differing pathophysiologic mechanisms [5].…”
Section: Introductionmentioning
confidence: 99%